0001140361-15-025490.txt : 20150626
0001140361-15-025490.hdr.sgml : 20150626
20150626083033
ACCESSION NUMBER: 0001140361-15-025490
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150625
FILED AS OF DATE: 20150626
DATE AS OF CHANGE: 20150626
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Asterias Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001572552
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461047971
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 230 CONSTITUTION DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 510-521-3390
MAIL ADDRESS:
STREET 1: 230 CONSTITUTION DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LeBuhn Richard T.
CENTRAL INDEX KEY: 0001428664
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36646
FILM NUMBER: 15953379
MAIL ADDRESS:
STREET 1: 25541 COMMERCENTRE DR.
CITY: LAKE FOREST
STATE: CA
ZIP: 92630-8870
4
1
doc1.xml
FORM 4
X0306
4
2015-06-25
0
0001572552
Asterias Biotherapeutics, Inc.
AST
0001428664
LeBuhn Richard T.
724 FIFTH AVENUE, 9TH FLOOR
NEW YORK
NY
10019
1
0
0
0
Series A Common Stock
2015-06-25
4
P
0
5000
4.4124
A
5000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.3899 to $4.42 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by him at each separate price on each date of sale.
/s/ Richard T. LeBuhn
2015-06-25